Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Guangxi Beisheng Pharmaceutical Co Ltd Cancels Asset Swap


Monday, 19 Aug 2013 08:00pm EDT 

Guangxi Beisheng Pharmaceutical Co Ltd announced that has decided to cancel the plan to swap its 100% stake in a Hangzhou-based property service company, valued at RMB 22,730,000, for a 100% stake in a Zhoushan-based river cargo transportation company (Company A), valued at RMB 3,668,000,000, with 33 shareholders of Company A, which was announced on April 10, 2013.